Published in Neurochem Res on December 01, 1985
Retracted SIRT1 suppresses beta-amyloid production by activating the alpha-secretase gene ADAM10. Cell (2010) 3.58
Neuropathological changes in scrapie and Alzheimer's disease are associated with increased expression of apolipoprotein E and cathepsin D in astrocytes. J Virol (1991) 2.47
Alzheimer's disease is associated with altered expression of genes involved in immune response and mitochondrial processes in astrocytes. Neurobiol Aging (2014) 0.93
Elevated protein levels of protein phosphatases PP-2A and PP-2B in astrocytes of Alzheimer's disease temporal cortex. J Neural Transm (Vienna) (1997) 0.77
Restoration of contact-inhibited growth to transformed cells by dibutyryl adenosine 3':5'-cyclic monophosphate. Proc Natl Acad Sci U S A (1971) 3.44
The role of excitatory amino acids and NMDA receptors in traumatic brain injury. Science (1989) 3.14
Growth control and cyclic alterations of cyclic AMP in the cell cycle. Nat New Biol (1972) 2.93
Difference in the cyclic adenosine 3',5'-monophosphate levels in normal and transformed cells. Nat New Biol (1972) 2.90
Delivery of insulin-like growth factor-I to the rat brain and spinal cord along olfactory and trigeminal pathways following intranasal administration. Neuroscience (2004) 2.86
Dementia lacking distinctive histologic features: a common non-Alzheimer degenerative dementia. Neurology (1990) 2.36
Cyclic membrane changes in animal cells: transformed cells permanently display a surface architecture detected in normal cells only during mitosis. Proc Natl Acad Sci U S A (1971) 2.30
Hemoglobin. A biologic fenton reagent. J Biol Chem (1984) 2.16
Effects of intranasal insulin on cognition in memory-impaired older adults: modulation by APOE genotype. Neurobiol Aging (2005) 2.15
Delivery of neurotrophic factors to the central nervous system: pharmacokinetic considerations. Clin Pharmacokinet (2001) 1.96
Pure hippocampal sclerosis: a rare cause of dementia mimicking Alzheimer's disease. Neurology (2000) 1.95
Rapid and reversible reduction of junctional permeability in cells infected with a temperature-sensitive mutant of avian sarcoma virus. J Cell Biol (1981) 1.67
Quantitative analysis of the olfactory pathway for drug delivery to the brain. Brain Res (1995) 1.65
Rise and fall of cyclic AMP required for onset of lymphocyte DNA synthesis. Science (1978) 1.42
Intranasal administration of insulin-like growth factor-I bypasses the blood-brain barrier and protects against focal cerebral ischemic damage. J Neurol Sci (2001) 1.42
Seizures in Alzheimer's disease: clinicopathologic study. J Geriatr Psychiatry Neurol (1995) 1.36
Intranasal administration of interferon beta bypasses the blood-brain barrier to target the central nervous system and cervical lymph nodes: a non-invasive treatment strategy for multiple sclerosis. J Neuroimmunol (2004) 1.29
Neurotoxicity of hemoglobin in cortical cell culture. Neurosci Lett (1993) 1.21
Pick's disease versus Alzheimer's disease: a comparison of clinical characteristics. Neurology (1993) 1.20
Hemoglobin potentiates central nervous system damage. J Clin Invest (1987) 1.19
Cyclic AMP levels in synchronized mammalian cells. Exp Cell Res (1972) 1.18
Non-invasive intranasal insulin-like growth factor-I reduces infarct volume and improves neurologic function in rats following middle cerebral artery occlusion. Neurosci Lett (2001) 1.18
Delivery of interferon-beta to the monkey nervous system following intranasal administration. Neuroscience (2008) 1.14
Bidirectional selection for susceptibility to ethanol withdrawal seizures in Mus musculus. Behav Genet (1985) 1.10
Bordetella adenylate cyclase toxin: entry of bacterial adenylate cyclase into mammalian cells. Adv Cyclic Nucleotide Protein Phosphorylation Res (1984) 1.10
Heme oxygenase-1 is induced in glia throughout brain by subarachnoid hemoglobin. J Cereb Blood Flow Metab (1998) 1.10
Hypohaptoglobinemia associated with familial epilepsy. J Exp Med (1985) 1.10
Cyclic AMP-dependent protein kinases from normal and SV40-transformed 3T3 cells. Nature (1976) 1.08
Binding of acetyl-CoA to chicken liver pyruvate carboxylase. J Biol Chem (1977) 1.05
Structural properties of pyruvate carboxylases from chicken liver and other sources. Proc Natl Acad Sci U S A (1975) 1.02
Transforming growth factor beta in Alzheimer's disease. Clin Diagn Lab Immunol (1994) 0.96
Hemoglobin potentiates excitotoxic injury in cortical cell culture. J Neurotrauma (1996) 0.95
Clinically diagnosed Alzheimer disease: neuropathologic findings in 650 cases. Alzheimer Dis Assoc Disord (1992) 0.95
Changes in extracellular amino acid neurotransmitters produced by focal cerebral ischemia. Neurosci Lett (1990) 0.95
Catecholamine hormone receptor differences identified on 3T3 and simian virus-transformed 3T3 cells. Proc Natl Acad Sci U S A (1977) 0.94
Chromosomal assignment of the gene for the human beta 2-adrenergic receptor. Proc Natl Acad Sci U S A (1983) 0.94
The effect of magnesium on oxidative neuronal injury in vitro. J Neurochem (1998) 0.94
Modulation of deferoxamine toxicity and clearance by covalent attachment to biocompatible polymers. Proc Natl Acad Sci U S A (1989) 0.92
Serum cytokine levels in patients with Alzheimer's disease. Clin Diagn Lab Immunol (1994) 0.92
Induction of heme oxygenase-1 after hyperosmotic opening of the blood-brain barrier. Brain Res (1998) 0.92
Neuroblastoma cell culture: membrane changes during cyclic AMP-induced morphological differentiation. Proc Soc Exp Biol Med (1972) 0.91
Risk factors in Alzheimer's disease: a clinicopathologic study. Neurology (1992) 0.91
Increased glycerol-3-phosphorylcholine in post-mortem Alzheimer's brain. Lancet (1985) 0.90
Down syndrome fibroblasts are hyperresponsive to beta-adrenergic stimulation. Proc Natl Acad Sci U S A (1981) 0.90
Validation of the NINCDS-ADRDA criteria regarding gait in the clinical diagnosis of Alzheimer disease. A clinicopathologic study. Alzheimer Dis Assoc Disord (1995) 0.90
Characterization of the AD7C-NTP cDNA expression in Alzheimer's disease and measurement of a 41-kD protein in cerebrospinal fluid. J Clin Invest (1997) 0.89
Catecholamine hormone receptors are reduced on chronic lymphocytic leukaemic lymphocytes. Nature (1977) 0.88
Free D-amino acids in human cerebrospinal fluid of Alzheimer disease, multiple sclerosis, and healthy control subjects. Mol Chem Neuropathol (1995) 0.88
Hallucinations and signs of parkinsonism help distinguish patients with dementia and cortical Lewy bodies from patients with Alzheimer's disease at presentation: a clinicopathological study. J Neurol Neurosurg Psychiatry (1997) 0.88
Free D- and L-amino acids in ventricular cerebrospinal fluid from Alzheimer and normal subjects. Amino Acids (1998) 0.87
Aldehyde dehydrogenase and ethanol preference in mice. J Biol Chem (1970) 0.87
Heme-oxygenase-1 induction in glia throughout rat brain following experimental subarachnoid hemorrhage. Brain Res (1996) 0.87
Bacterial endotoxin (lipopolysaccharide) stimulates the rate of iron oxidation. J Endotoxin Res (2000) 0.86
Intranasal deferoxamine improves performance in radial arm water maze, stabilizes HIF-1α, and phosphorylates GSK3β in P301L tau transgenic mice. Exp Brain Res (2012) 0.86
G2+M arrest of cultured mammalian cells after incorporation of tritium-labeled nucleosides. J Cell Physiol (1977) 0.86
Posterior cortical atrophy: neuropathological correlations. Arch Neurol (1996) 0.86
Variations in alcohol metabolism: influence of sex and age. Pharmacol Biochem Behav (1976) 0.86
Plasma membrane studies on drug sensitive and resistant cell lines. I. Cross resistance and membrane enzyme coordination (ouabain/cAMP/Na+/K+ ATPase/adenylate cyclase). Exp Cell Res (1977) 0.85
Agglutinability by plant lectins increases after RNA virus transformation. Virology (1972) 0.85
Ganglioside monoclonal antibody (A2B5) labels Alzheimer's neurofibrillary tangles. Neurology (1987) 0.85
Altered aspartate in Alzheimer neurofibrillary tangles. Neurochem Res (1992) 0.85
Cyclic AMP, ATP and cell contact. Nature (1974) 0.85
Cell-surface changes after infection with oncogenic viruses: requirement for synthesis of host DNA. Science (1971) 0.85
Inhibitors of cyclic-nucleotide phosphodiesterase induce morphological differentiation of mouse neuroblastoma cell culture. Exp Cell Res (1972) 0.85
Shared genetic susceptibility of type 1 (insulin-dependent) and type 2 (non-insulin-dependent) diabetes mellitus: contributions of HLA and haptoglobin. Diabetologia (1991) 0.84
Induction of heme oxygenase-1 (HO-1) in glia after traumatic brain injury. Brain Res (1996) 0.84
Ultrastructure of excitotoxic neuronal death in murine cortical culture. Brain Res (1995) 0.83
Human brain tubulin purification: decrease in soluble tubulin with age. Neurochem Res (1985) 0.83
Hypohaptoglobinemia: a possible predisposition to epilepsy. Trans Assoc Am Physicians (1984) 0.83
Experimental metastasis correlates with cyclic AMP accumulation in B16 melanoma clones. Nature (1984) 0.83
The use of the ultracentrifuge to determine the catalytically competent forms of enzymes with more than one oligomeric structure. Multiple reacting forms of pyruvate carboxylase from chicken and rat liver. J Biol Chem (1978) 0.83
Assessment of red cell sodium transport in essential hypertension. Blood (1982) 0.83
Fluorescence spectroscopic studies of Huntington fibroblast membranes. Am J Hum Genet (1981) 0.82
Induction of heme oxygenase-1 (HO-1) after traumatic brain injury in the rat. Neurosci Lett (1995) 0.81
Catecholamine-sensitive guanylate cyclase from human caudate nucleus. J Neurochem (1980) 0.81
Effect of stimulus on the chemical composition of human tears. Am J Ophthalmol (1981) 0.81
Cyclic AMP, membrane transport and cell division. I. Effects of various chemicals on cyclic AMP levels and rate of transport of neucleosides, hypoxanthine and deoxyglucose in several lines of cultured cells. J Cell Physiol (1975) 0.81
Density-dependent phosphorylation of a specific protein in cultured cells. Nature (1977) 0.81
Retracted Intranasal delivery of insulin and a nitric oxide synthase inhibitor in an experimental model of amyotrophic lateral sclerosis. Neuroscience (2008) 0.80
Racemized D-aspartate in Alzheimer neurofibrillary tangles. Brain Res Bull (1992) 0.80
cAMP metabolism in B16 melanoma clones during the formation of experimental and spontaneous metastases. Int J Cancer (1986) 0.80
NMDA neurotoxicity in murine cortical cell cultures is not attenuated by hemoglobin or inhibition of nitric oxide synthesis. Neurosci Lett (1993) 0.80
Endogenous cyclic AMP does not modulate transport of hexoses, nucleosides, or nucleobases in Chinese hamster ovary cells. J Supramol Struct (1979) 0.80
Competitive inhibition of the transport of nucleosides, hypoxanthine, choline and deoxyglucose by theophylline, papaverine and prostaglandins. Biochem Biophys Res Commun (1974) 0.80
Elution of the regulatory subunit of cAMP-dependent protein kinase Type I isozyme derived from epididymal fat within the type II isozyme chromatographic peak. Biochem Biophys Res Commun (1983) 0.80
Focal hyperexpression of hemeoxygenase-1 protein and messenger RNA in rat brain caused by cellular stress following subarachnoid injections of lysed blood. J Neurosurg (1996) 0.79
Seasonal distribution of births in Alzheimer's disease. Int Psychogeriatr (1991) 0.79
Biochemical regulation of adenylate cyclase in murine melanoma clones with different metastatic properties. Int J Cancer (1986) 0.79
Enzyme activities and ethanol preference in mice. Biochem Genet (1968) 0.79
Desensitization of LLC-PK1 cells by vasopressin results in receptor down-regulation. Mol Cell Endocrinol (1985) 0.79
Ethanol and acetaldehyde metabolism in the pregnant mouse. Drug Alcohol Depend (1977) 0.79
Anti-oxidants prevent focal rat brain injury as assessed by induction of heat shock proteins (HSP70, HO-1/HSP32, HSP47) following subarachnoid injections of lysed blood. Brain Res Mol Brain Res (1999) 0.79
Racial differences in hypertension-associated red cell sodium permeability. Nature (1982) 0.79
Status selective white flight and central city population change: a comparative analysis. J Reg Sci (1980) 0.79
Sustained induction of heme oxygenase-1 in the traumatized spinal cord. Exp Neurol (2000) 0.79
Heme from Alzheimer's brain inhibits muscarinic receptor binding via thiyl radical generation. Brain Res (1997) 0.79